By comparing Her2/neu expression with clinicopathological features in patients with gastric adenocarcinoma and statistical analysis of data, a significant correlation was not found in between the expression of tumor marker, gender, tumor location, Lauren classification, histologic grade and the number of involved lymph nodes (p>0.05). This evidence concerns the gene ERBB2 and gastric adenocarcinoma.